Navigation Links
New company announcement: TERGUS PHARMA
Date:6/12/2012

RESEARCH TRIANGLE PARK, N.C., June 12, 2012 /PRNewswire-iReach/ -- In response to company growth and expansion of topical pharmaceutical product development services, Analytical Solutions, Inc. (ASI) is pleased to announce today that it is changing its name to Tergus Pharma, LLC, to better echo the company's new growth trajectory.

Tergus Co-Founder and CEO, Dr. Vijendra NALAMOTHU, most recently Head of Dermatology R&D for Promius Pharma and Dr. Reddy's Laboratories, brings 18 years of topical drug product development and commercialization experience to Tergus clients. Since 1994, Tergus Co-Founder and President, Dr. Kailas Thakker, has been providing quality analytical services to the pharmaceutical industry with an emphasis on In Vitro Release Testing (IVRT), functional testing for semisolids and topical products.

Tergus (Latin for "skin") is now providing dermatology drug development services from concept to commercialization.  With the acquisition of new equipment and strategic additions to the scientific team, Tergus Pharma is pleased to announce that it is now servicing its clients with a broader range of topical drug development services, including product development strategy & design; target product profile development; formulation development; analytical method development & validation; preclinical & clinical supplies manufacturing; program management & logistics leadership; scale-up & technology transfer oversight; regulatory CMC consulting; disease model development; clinical development strategy; and development plan creation to ensure fastest path to in vivo or clinical proof of concept studies.

Tergus' core expertise will remain focused in topical dosage forms, including creams, ointments, lotions, liquids, suspensions, gels, hydrogels, pastes, pump sprays, topical aerosols, foams, microencapsulation, liposomes, suppositories and nail lacquers.

Think Topicals. Think Tergus

About Tergus Pharma

Tergus Pharma, LLC is a privately held dermatology-focused organization offering complete pharmaceutical product development services. Tergus' GMP/GLP compliant, state of the art laboratories are located in Research Triangle Park, North Carolina. For additional information please visit www.TergusPharma.com 

Media Contact: Ms. Kathy Meserve, Tergus Pharma, +1(919) 549-9700 Ext.105, KMeserve@TergusPharma.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Tergus Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Company To Present At The William Blair Growth Stock Conference
2. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
3. Masimo to Present at William Blair & Company 32nd Annual Growth Stock Conference
4. K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity
5. CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
6. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
7. Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager
8. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
9. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
10. The Female Health Company Reports Second Quarter Operating Results
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
(Date:3/24/2017)... March 24, 2017 Today Stock-Callers.com have ... which are: Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), ... SSH ). These companies are part of the ... on Thursday, March 23 rd , 2017, with the NYSE ... of health care companies in the S&P 500 were down ...
Breaking Medicine Technology:
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... scale; from third world countries to hospitals in the United States, it’s a ... conversation on the current obstacles facing infection prevention and offers strategies for the ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA ... does not obey the rules Congress has directed the CBO to follow. The CBO ... reform would restore. Yet, it estimates a reduction in employer-based coverage due to the ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... planning, and related services to families and business owners across eastern Michigan, is ... feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... Society (ONS) wanted to create a communications platform that positions them as the ... Elliance and ONS reinvented their online publication as an always-on, always-fresh news, views ...
(Date:3/24/2017)... Westchester County, NY (PRWEB) , ... March 24, 2017 , ... ... in Somers and White Plains, N.Y., is pleased to announce Westchester resident Lauren C. ... as a law clerk for the firm, will concentrate her practice in elder law, ...
Breaking Medicine News(10 mins):